The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I’d say the opening few chapters seemed quite positive but agree the ending was wide open with the possibility of gloom.
I’m no expert but I am suspicious
Schroders secretly sold from November and didn’t issue a TR1 until they’d finished.
It did at least show a reason for the big drop but didn’t explain why the shorts didn’t clear out at 15p.
I’m a believer in PFC but something is going on here
The last RNS stated they still owned circa 3%
Is it likely that they are selling their remaining 15 million or so shares? Would go some way to explaining the large after hrs trades that seemingly have no impact on the SP at the following open?
MW have dropped below 0.5%
The try of the lucky 7 are borrowing 11.49%
They failed to get out in December at 16/17p
They didn’t run for cover at 41p
They didn’t even leave after a retrace to 25p, now 31 and looking like a period of decline for now and possibly until we get an update on cash flow etc.
$8B worth of contracts wasn’t enough for the SP to recover properly ie: above 100p and beyond.
As time ticks past we get closer to a resolution of current situation, therefore I’m somewhat miffed by the shorts remaining?
Large spread and no action whatsoever, I’m watching the same in ESKN, something happening in the background as this is most irregular behavior.
Lots of people posting takeover etc, seeming more and more likely as indicated by no director buys.
What we all want here is the shorts to leave.
3 large transactions after the close yesterday, could be anything or anyone but if it is indeed a short selling their position then we will find out after todays close. Once they start to properly leave, I dare say it’ll be an Efren for all as PI’s will smell blood and pile in. Can’t complain too much as without them the share price would not be this low.
Mav, couldn’t agree more.
You have to make a comparison with similar companies. Wood group springs to mind, Apollo offered $1.5Billion which was rejected by the board for being too cheap. Although wood don’t have the same cash flow issues it does make you wonder how a very similar business can be valued so low.
I remain convinced 100p is too cheap for pfc, pre-pandemic was 400p due in large to the SFO investigation which is all firmly in the past now. COVID hurt a lot of businesses but agin, that’s all over now. The future of PFC is looking brighter by the day.
GLALTH
Mary, thanks for the response, seems sensible if still cheap at 60-70p
Someone, can’t remember who cross posted recently on helium global, I read the RNS however not having any knowledge of the business I threw £500 as a quick punt. Slice and left the profit to ride. Only made £107 which is now £324 and I’m kicking myself for not putting more in 245% in 3 days so thankyou to whomever cross posted as although I’m not brave enough to have made any real money on that one, watching it rise like a phoenix is fun and I truly believe something similar will happen with PFC.
Interesting tactic Mary
More or less what I’ve been doing with PFC for 2 or more years, didn’t work out for me in November/December but as I kept buying the dips which were almost everyday my average did obviously reduce. Now averaging 29.3p so I’m up on paper approximately 9%.
I did reduce on the last spike but at 33p not 40p, then added again at 25-27p.
My issue with PFC is it appears ridiculously under valued and without the shorts I think we would be somewhere around the 100p mark. Then once the funding issue is sorted a lot more given the backlog and future prospects of the company.
I’d be interested to know what your slice price target is?